» Articles » PMID: 30687082

Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action of Formula for the Treatment of Gastrointestinal Diseases

Overview
Journal Front Pharmacol
Date 2019 Jan 29
PMID 30687082
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-components Traditional Chinese Medicine (TCM) treats various complex diseases (multi-etiologies and multi-symptoms) via herbs interactions to exert curative efficacy with less adverse effects. However, the ancient Chinese compatibility theory of herbs formula still remains ambiguous. Presently, this combination principle is dissected through a systems pharmacology study on the mechanism of action of a representative TCM formula, (HXZQ) prescription, on the treatment of functional dyspepsia (FD), a chronic or recurrent clinical disorder of digestive system, as typical gastrointestinal (GI) diseases which burden human physical and mental health heavily and widely. In approach, a systems pharmacology platform which incorporates the pharmacokinetic and pharmaco-dynamics evaluation, target fishing and network pharmacological analyses is employed. As a result, 132 chemicals and 48 proteins are identified as active compounds and FD-related targets, and the mechanism of HXZQ formula for the treatment of GI diseases is based on its three function modules of anti-inflammation, immune protection and gastrointestinal motility regulation mainly through four, i.e., PIK-AKT, JAK-STAT, Toll-like as well as Calcium signaling pathways. In addition, HXZQ formula conforms to the ancient compatibility rule of "" due to the different, while cooperative roles that herbs possess, specifically, the direct FD curative effects of (serving as drug), the anti-bacterial efficacy and major accompanying symptoms-reliving bioactivities of and (as ), the detoxication and ADME regulation capacities of (as ), as well as the minor symptoms-treating efficacy of the rest 7 herbs (as ). This work not only provides an insight of the therapeutic mechanism of TCMs on treating GI diseases from a multi-scale perspective, but also may offer an efficient way for drug discovery and development from herbal medicine as complementary drugs.

Citing Articles

Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota.

Wu Z, Yao L, Guo J, Xu Z, Wang Z Open Life Sci. 2024; 19(1):20220964.

PMID: 39655192 PMC: 11627061. DOI: 10.1515/biol-2022-0964.


Simultaneous determination of multiple components in rat plasma by UPLC-MS/MS for pharmacokinetic studies after oral administration of extract.

Zhu Y, Ouyang H, Lv Z, Yao G, Ge M, Cao X Front Pharmacol. 2024; 15:1293464.

PMID: 38841366 PMC: 11150675. DOI: 10.3389/fphar.2024.1293464.


Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.

Li P, Wang D, Yang X, Liu C, Li X, Zhang X Molecules. 2024; 29(8).

PMID: 38675723 PMC: 11054111. DOI: 10.3390/molecules29081901.


The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19.

Gasmi A, Noor S, Dadar M, Semenova Y, Menzel A, Benahmed A Curr Pharm Des. 2024; 30(14):1060-1074.

PMID: 38523518 DOI: 10.2174/0113816128217263240220060252.


essential oil affects anxiety- and depressive-like behaviors and the gut microbiota in chronic unpredictable mild stress model rats.

Ouyang P, Kang D, You W, Shen X, Mo X, Liu Y Front Nutr. 2024; 11:1303002.

PMID: 38419848 PMC: 10899464. DOI: 10.3389/fnut.2024.1303002.


References
1.
Bae E, Han M, Kim D . In vitro anti-Helicobacter pylori activity of some flavonoids and their metabolites. Planta Med. 1999; 65(5):442-3. DOI: 10.1055/s-2006-960805. View

2.
Williams C, Mann M, DuBois R . The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 2000; 18(55):7908-16. DOI: 10.1038/sj.onc.1203286. View

3.
Vaughan C, Aherne A, Lane E, Power O, Carey R, OConnell D . Identification and regional distribution of the dopamine D(1A) receptor in the gastrointestinal tract. Am J Physiol Regul Integr Comp Physiol. 2000; 279(2):R599-609. DOI: 10.1152/ajpregu.2000.279.2.R599. View

4.
Chulada P, Thompson M, Mahler J, Doyle C, Gaul B, Lee C . Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 2000; 60(17):4705-8. View

5.
Chinetti G, Fruchart J, Staels B . Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res. 2000; 49(10):497-505. DOI: 10.1007/s000110050622. View